We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-4.45%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.08B
AUM Growth
+$322M
Cap. Flow
+$648M
Cap. Flow %
21%
Top 10 Hldgs %
37.4%
Holding
321
New
89
Increased
78
Reduced
45
Closed
96

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32M
2
CCCC icon
C4 Therapeutics
CCCC
+$14.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$14.1M
4
AMRS
Amyris Inc.
AMRS
+$11M
5
TECH icon
Bio-Techne
TECH
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$14.1M
2
DXCM icon
DexCom
DXCM
+$14.1M
3
ICUI icon
ICU Medical
ICUI
+$14M
4
LIVN icon
LivaNova
LIVN
+$12.2M
5
OLPX
Olaplex Holdings
OLPX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Materials 0.35%
3 Industrials 0.17%
4 Consumer Discretionary 0.07%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OEF icon
1
PUT
iShares S&P 100 ETF
OEF
$20.6B
$251M 8.15%
1,325,700
+650,700
+96% +$134M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$203M 6.59%
450,000
-150,000
-25% -$66.8M
XNTK icon
3
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$125M 4.06%
1,391,800
+1,111,800
+397% +$158M
QQQ icon
4
PUT
Invesco QQQ Trust
QQQ
$484B
$109M 3.53%
300,000
-200,000
-40% -$71M
ARKG icon
5
PUT
ARK Genomic Revolution ETF
ARKG
$1.73B
$103M 3.35%
2,250,000
+1,750,000
+350% +$83.4M
ILCV icon
6
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
$85.3M 2.77%
1,400,000
+498,400
+55% +$33.8M
CUTR
7
DELISTED
Cutera, Inc.
CUTR
$74.1M 2.4%
1,074,151
-41,260
-4% -$1.67M
BIIB icon
8
CALL
Biogen
BIIB
$30.7B
$73.5M 2.38%
348,900
+122,200
+54% +$26.6M
ESTA icon
9
Establishment Labs
ESTA
$2.28B
$64.9M 2.1%
962,494
-163,704
-15% -$9.57M
ESTA icon
10
CALL
Establishment Labs
ESTA
$2.28B
$63.7M 2.07%
945,200
+701,900
+288% +$41M
ARKK icon
11
PUT
ARK Innovation ETF
ARKK
$6.31B
$59.7M 1.93%
900,000
+550,000
+157% +$38.8M
VRAY
12
DELISTED
ViewRay, Inc.
VRAY
$53.2M 1.72%
13,561,808
-545,052
-4% -$2.32M
INSP icon
13
Inspire Medical Systems
INSP
$1.74B
$52.2M 1.69%
203,442
-11,000
-5% -$2.51M
GKOS icon
14
CALL
Glaukos
GKOS
$10.6B
$50.2M 1.63%
868,100
+17,500
+2% +$926K
MDT icon
15
CALL
Medtronic
MDT
$112B
$44.4M 1.44%
+400,000
New +$42.3M
CUTR
16
CALL
DELISTED
Cutera, Inc.
CUTR
$43.8M 1.42%
635,000
+142,200
+29% +$5.75M
NSTG
17
DELISTED
NanoString Technologies, Inc.
NSTG
$42.4M 1.38%
1,220,332
+36,772
+3% +$1.27M
MDT icon
18
PUT
Medtronic
MDT
$112B
$39.9M 1.3%
360,000
+35,000
+11% +$3.7M
LIVN icon
19
CALL
LivaNova
LIVN
$4.2B
$31.2M 1.01%
381,600
+250,800
+192% +$19.5M
BAX icon
20
PUT
Baxter International
BAX
$14.2B
$31M 1.01%
+400,000
New +$33.5M
BIIB icon
21
Biogen
BIIB
$30.7B
$31M 1%
+147,135
New +$32M
BDX icon
22
PUT
Becton Dickinson
BDX
$48.2B
$29.9M 0.97%
115,313
+59,450
+106% +$15.3M
ZBH icon
23
CALL
Zimmer Biomet
ZBH
$18.4B
$28.8M 0.93%
+225,000
New +$27.1M
LIVN icon
24
LivaNova
LIVN
$4.2B
$28.4M 0.92%
347,498
-157,269
-31% -$12.2M
JNJ icon
25
PUT
Johnson & Johnson
JNJ
$625B
$26.6M 0.86%
+150,000
New +$25.5M
1
2 3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Pura Vida Investments held 321 positions worth $3.08B, up 12% from $2.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $648M of net new capital in Q1 2022, opening 89 new positions and adding to 78 existing holdings. Its largest new stake was Biogen: 147,135 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was ICU Medical, an estimated $14M trimmed.

  • Pura Vida Investments's largest Q1 2022 buy was Biogen: 147,135 shares worth $31M.
  • Pura Vida Investments added most to C4 Therapeutics in Q1 2022, an estimated $14.5M increase.
  • Pura Vida Investments's biggest Q1 2022 reduction was ICU Medical, cutting an estimated $14M.
  • Pura Vida Investments fully exited Natera in Q1 2022, selling an estimated $14.1M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $3.08B portfolio in Q1 2022.
  • Pura Vida Investments opened 89 new positions and closed 96 in Q1 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $3.08B.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.